Presidio Pharmaceuticals, Inc.
Eric Ruby Joins Presidio Pharmaceuticals, Inc. as Vice President of Regulatory Affairs
Published in Drug Law Weekly, January 26th, 2010
"The addition of Eric to our team significantly contributes to Presidio's clinical development of our NS5A inhibitor in 2010," said Omar Haffar, Founder, President and Chief Executive Officer. "Eric's extensive background in regulatory affairs will enhance and complement Presidio's existing management team and strengthen our ability to create value for the company and our investors. All of us at Presidio look forward to working with Eric and to maintaining our pace of building a vibrant drug development organization."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-26)
More Articles from Drug Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives $2.5 Million Milestone Payment - Adeptra
Adeptra Survey Reveals Banks and Card Issuers Are Investing in Technology to Speed-up and Improve Reporting and Prevention of Fraud - Aerospace Industries Association
Mandell Named Head of Membership and Business Development - Age and Aging
Dr. Zein Obagi, Preeminent Inventor of Skin Care Products, Challenges Anti-Competitive Practices of Obagi Medical Products - ARCA biopharma, Inc.
ARCA biopharma Receives Notice of Allowance for Patent for Treating Heart Failure Patients with Bucindolol Based on Genetic Testing - BioNJ
BioNJ to Kick Off 2010 with 17th Annual Meeting to Support New Jersey's Biotech Innovation - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
